1.One stage cholecystectomy during radical gastrectomy for gastric cancer with gallbladder disease
Guojing ZHANG ; Ruotong LI ; Zhicheng ZHAO ; Weidong LI ; Weihua FU
Chinese Journal of General Surgery 2016;31(1):40-42
Objective To evaluate radical gastrectomy combined with cholecystectomy for gastric cancer patients with concomitant gallbladder disease.Methods Clinical data of 702 gastric cancer patients undergoing radical gastrectomy (614 patients) only or combined with cholecystectomy during radical gastrectomy from October 2009 to September 2014 in our department was retrospectively analyzed.Results The operating time of patients with simultaneous cholecystectomy was(348 ± 111)min.the operating time of patients with radical gastrectomy only was (274 ± 89) min (t =3.812,P < 0.05).Perioperative and postoperative complications,hospitalization expenses and 5-year survival rates were not statistically significant (P > 0.05).Conclusions Radical gastrectomy with cholecystectomy for gastric cancer with gallbladder disease patients is safe and feasible.
2. AZD5363 inhibits cell proliferation, migration and induces apoptosis of breast cancer MDA-MB-231 cells
Tumor 2017;37(8):824-830
Objective: To investigate the effects of AZD5363, an inhibitor of protein kinase B (Akt), on proliferation, migration and apoptosis of human breast cancer cell line MDA-MB-231, and to further clarify their possible molecular mechanisms Methods: After treatment with different concentrations (0.5, 1, 5, 10, 20 and 50 μmol/L) of AZD5363, the viability of MDA-MB-231 cells was detected by MTT assay, the cell cycle distribution was analyzed by FCM, the cell migration ability was detected by wound healing test and Transwell chamber assay, the cell apoptosis rate was detected by TUNEL method. Then the expression levels of cell cycle- and apoptosis-related proteins were measured by Western blotting. Results: AZD5363 suppressed the cell viability in a dose-dependent manner (P < 0.05), and arrested the cell cycle progression at S phase by up-regulating the expression of p53 and down-regulating the expression of cyclin B1 (all P < 0.05). AZD5363 significantly inhibited the cell migration (P < 0.05), and induced the cell apoptosis (P < 0.05) by activating caspase-3 and poly (ADP-ribose) polymerase (PARP) proteins (both P < 0.05). Conclusion: AZD5363 can inhibit cell activity and migration, and induce apoptosis of human breast cancer cell line MDA-MB-2 31, thereby exhibiting its anticancer activity.
3.Perifosine regulates human brain glioma U251 cell proliferation, apopto-sis and autophagy through suppression of PI3 K/Akt pathway
Ruotong LI ; Li WANG ; Ting CAO ; Shengwen CHEN ; Hongrong FEI ; Fengze WANG
Chinese Journal of Pathophysiology 2016;32(4):644-650
AIM:To investigate the effect of perifosine, an inhibitor of protein kinase B ( PKB/Akt) , on the cell cycle, apoptosis and autophagy in human brain glioma U251 cells, and to determine the relationship between perifos-ine-induced autophagy and apoptosis of glioma.METHODS:The cell growth inhibition was determined by MTT assay. The cell cycle distribution of U251 cells was examined by flow cytometry.The cell apoptosis was analyzed by Annexin V-FITC apoptosis detection kit.The protein expression of P21, P27, cyclin B1, caspase-9 and PARP was examined by Wes-tern blot analysis.The distribution and expression of LC3-Ⅱ, an autophagy marker, was observed to determine the effect of perifosine-induced autophagy.RESULTS:Perifosine inhibited the cell viability in a dose-dependent manner.In perifos-ine-treated U251 cells, the cell cycle was arrested in G2 phase and the expression of cyclin B1 was inhibited.Perifosine in-duced apoptosis of U251 cells through activation of caspase-9 cleavage, PARP cleavage and survivin inhibition.In addi-tion, suppression of autophagy by chloroquin, an inhibitor of autophagy, increased the number of apoptotic cells.CON-CLUSION:Perifosine inhibits cell proliferation and triggers apoptosis and autophagy in human U251 cells.Blocking auto-phagy magnifies perifosine-induced glioma cell apoptosis.
4.Characteristics of the VP1 gene hypervariable region in EV68 strains isolated in China
Yancui WANG ; Jiaqi LI ; Jingjing WANG ; Lei GUO ; Jie SONG ; Ruotong NING ; Huiwen ZHENG ; Hui WANG ; Longding LIU
Chinese Journal of Microbiology and Immunology 2016;36(5):333-339
Objective To investigate the characteristics of VP1 gene hypervariable region in hu-man enterovirus type 68(HEV68)strains isolated in China. Methods Nucleotide sequences of the VP1 gene in the Chinese strains and strains isolated in other countries were aligned by using Clustal W in the MEGA6 program. The phylogenetic trees were constructed by using Neighbor-Joining(NJ)method in the MEGA6 program. Sequence of the amino acids encoded by that region was analyzed by compared with that of the standard strain Fermon. Results A total of 80 strains of EV68 had been isolated in China by the end of 2015. Most of the mutations occurred in BC and DE loops. The mutation sites lied in the VP1 gene of Chi-nese isolates were at 83,89,91,94,96,97,98,102,109,139,141,142,143,144 and 147. Glycine was missing from most of the amino acid sequences encoded by the VP1 gene of Chinese strains. The phylo-genetic analysis indicated that 53 and 21 EV68 strains isolated in China belonged to B and C clades,respec-tively. Conclusion Compared with the standard strain Fermon,the Chinese strains changed a lot in BC-loop and DE-loop,which were associated with the antigenicity and virulence of EV68. The EV68 strains iso-lated in China belonged to B and C clades.
5. Review on the progress regarding the intervention mapping protocol
Ruotong LI ; Peishan NING ; Jie LI ; Wanhui WANG ; Guoqing HU
Chinese Journal of Epidemiology 2019;40(4):488-492
Along with the significant development on both theory and practice of health promotion programs, the application of behavioral and social science theories has also been advanced in the fields of design and evaluation regarding the intervention-related studies. Intervention mapping is a new planning protocol, efficiently used to develop, implement, and evaluate health promotion related intervention programs. In this article, we are briefly introducing the basic concepts, implementation steps, specific requirements, as well as reviewing the current progress in methodologies, application that are related to intervention mapping, so as to provide reference for health intervention research studies, domestically.
6.Analysis of biochemical and genetic screening results for neonatal methylmalonic acidemia
Yulin LI ; Meng SUN ; Panpan LI ; Liping TIAN ; Yuanfang GUO ; Gaijie LI ; Ruotong LI ; Yan YAN ; Qing LI ; Hui ZOU
Chinese Journal of Applied Clinical Pediatrics 2023;38(1):54-59
Objective:To investigate the incidence rate and gene variation of methylmalonic academia (MMA) in Ji′nan city by analyzing biochemical and genetic screening results, and to explore the carrier frequency of MMA-related pathogenic genes in the population in Ji′nan.Methods:The children diagnosed with MMA by tandem mass spectrometry screening in Ji′nan Neonatal Disease Screening Centre from May 2011 to May 2022 were enrolled in this study.Their genetic test results were retrospectively analyzed and summarized.The dried heel blood tablets collected from 6 800 newborns were tested for neonatal gene screening. MMAA, MMAB, MMACHC and MMUT genes in 4 800 cases were detected by high-throughput sequencing+ target area capture technology.Ultra-multiplex polymerase chain reaction+ target gene locus capture technology was used to detect 174 target loci of 8 genes related to MMA in 2 000 cases.The hotspot mutation and related gene carrier rate of MMA were analyzed. Results:A total of 367 452 newborns were screened by tandem mass spectrometry, and 103 cases (56 males and 47 females) were diagnosed with MMA by screening.The estimated incidence of MMA was 1∶3 567.Among the 103 MMA cases, 76 were genetically diagnosed, and 4 gene variants of MMA ( MMAHC, MMUT, MMAA, MMADHC) were identified.A total of 6 800 neonates underwent neonatal genetic screening.Three of them were diagnosed with MMA.About 318 infants carried pathogenic variants of MMA, with a total carrier rate of 4.68%.Specifically, the carrier rates of MMACHC and MMUT gene variants were 3.09%(210/6 800) and 1.43% (97/6 800), respectively. Conclusions:MMA is the most common organic acid metabolism disorder in our country.The incidence and carrier rate of this disease are high in Jinan city.Neonatal genetic screening is an important supplement to neonatal biochemical screening.Carrier screening for MMA-related pathogenic genes is recommended for couples of childbearing age in Jinan.
7.A widely adaptable approach to generate integration-free iPSCs from non-invasively acquired human somatic cells.
Zhichao DING ; Lina SUI ; Ruotong REN ; Yanjun LIU ; Xiuling XU ; Lina FU ; Ruijun BAI ; Tingting YUAN ; Ying HAO ; Weiqi ZHANG ; Huize PAN ; Wensu LIU ; Han YU ; Concepcion Rodriguez ESTEBAN ; Xiaobing YU ; Ze YANG ; Jian LI ; Xiaomin WANG ; Juan Carlos IZPISUA BELMONTE ; Guang-Hui LIU ; Fei YI ; Jing QU
Protein & Cell 2015;6(5):386-389
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Cell Culture Techniques
;
methods
;
Child
;
Female
;
Humans
;
Induced Pluripotent Stem Cells
;
cytology
;
metabolism
;
Male
;
Middle Aged
8.Imprinting genes modified parthenogenetic embryonic stem cells produce full-term mouse via tetraploid complementation.
Xu LI ; Keli PENG ; Jinxin ZHANG ; Qian GAO ; Wenhao ZHANG ; Ruotong HUA ; Ling SHUAI
Chinese Journal of Biotechnology 2019;35(5):910-918
Parthenogenetic embryonic stem cells (pESCs) derived from bi-maternal genomes do not have competency of tetraploid complementation, due to lacking of paternal imprinting genes. To make pESCs possess fully development potentials and similar pluripotency to zygote-derived ESCs, we knocked out one allelic gene of the two essential maternal imprinting genes (H19 and IG) in their differentially methylated regions (DMR) via CRISPR/Cas9 system and obtained double knock out (DKO) pESCs. Maternal pESCs had similar morphology, expression levels of pluripotent makers and in vitro neural differentiation potentials to zygotes-derived ESCs. Besides that, DKO pESCs could contribute to full-term fetuses through tetraploid complementation, proving that they held fully development potentials. Derivation of DKO pESCs provided a type of major histocompatibility complex (MHC) matched pluripotent stem cells, which would benefit research in regenerative medicine.
Animals
;
Embryonic Stem Cells
;
Gene Knockout Techniques
;
Genomic Imprinting
;
Mice
;
Parthenogenesis
;
Pluripotent Stem Cells
;
Regenerative Medicine
;
Tetraploidy
9.Deciphering primate retinal aging at single-cell resolution.
Si WANG ; Yuxuan ZHENG ; Qingqing LI ; Xiaojuan HE ; Ruotong REN ; Weiqi ZHANG ; Moshi SONG ; Huifang HU ; Feifei LIU ; Guoqiang SUN ; Shuhui SUN ; Zunpeng LIU ; Yang YU ; Piu CHAN ; Guo-Guang ZHAO ; Qi ZHOU ; Guang-Hui LIU ; Fuchou TANG ; Jing QU
Protein & Cell 2021;12(11):889-898
10.Chemical screen identifies a geroprotective role of quercetin in premature aging.
Lingling GENG ; Zunpeng LIU ; Weiqi ZHANG ; Wei LI ; Zeming WU ; Wei WANG ; Ruotong REN ; Yao SU ; Peichang WANG ; Liang SUN ; Zhenyu JU ; Piu CHAN ; Moshi SONG ; Jing QU ; Guang-Hui LIU
Protein & Cell 2019;10(6):417-435
Aging increases the risk of various diseases. The main goal of aging research is to find therapies that attenuate aging and alleviate aging-related diseases. In this study, we screened a natural product library for geroprotective compounds using Werner syndrome (WS) human mesenchymal stem cells (hMSCs), a premature aging model that we recently established. Ten candidate compounds were identified and quercetin was investigated in detail due to its leading effects. Mechanistic studies revealed that quercetin alleviated senescence via the enhancement of cell proliferation and restoration of heterochromatin architecture in WS hMSCs. RNA-sequencing analysis revealed the transcriptional commonalities and differences in the geroprotective effects by quercetin and Vitamin C. Besides WS hMSCs, quercetin also attenuated cellular senescence in Hutchinson-Gilford progeria syndrome (HGPS) and physiological-aging hMSCs. Taken together, our study identifies quercetin as a geroprotective agent against accelerated and natural aging in hMSCs, providing a potential therapeutic intervention for treating age-associated disorders.